Metraipolis › archive › dc_68331ee90faa

Efficacy of Immunostimulatory Adjuvants and Nano-Adjuvants in Current SARS-CoV-2 Vaccines: A Comprehensive Review — Europe PMC PMID:41255382

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41255382
DOI: 10.1002/hsr2.71405
License (as archived): solo-consultazione
Archived: 2026-11-08T11:58:04.753Z
SHA-256 of the archived text: bba09affffe0475049bc402126f21f8e969db80e6ddad67938265b6c2e8b1a29
Stable URL of this page: https://metraipolis.com/documento/dc_68331ee90faa

How to cite

Efficacy of Immunostimulatory Adjuvants and Nano-Adjuvants in Current SARS-CoV-2 Vaccines: A Comprehensive Review — Europe PMC PMID:41255382 — Europe PMC (en), https://europepmc.org/article/MED/41255382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68331ee90faa (Metraipolis archive dc_68331ee90faa, sha256 bba09affffe0475049bc402126f21f8e969db80e6ddad67938265b6c2e8b1a29)

BibTeX

@misc{dc68331ee90faa,
  title = {Efficacy of Immunostimulatory Adjuvants and Nano-Adjuvants in Current SARS-CoV-2 Vaccines: A Comprehensive Review — Europe PMC PMID:41255382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41255382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68331ee90faa; sha256 bba09affffe0475049bc402126f21f8e969db80e6ddad67938265b6c2e8b1a29},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41255382. Agents can read the archived copy with the MCP tool read_document.